Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides a Corporate Update Portfolio News / Karina Tin January 27, 2022 Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides a Corporate Update Read More »
ORIC Pharmaceuticals Announces Regulatory Clearance of Clinical Trial Application for ORIC-114 in Advanced Solid Tumors with EGFR or HER2 Exon 20 Alterations or HER2 Amplifications Portfolio News / Karina Tin January 25, 2022 ORIC Pharmaceuticals Announces Regulatory Clearance of Clinical Trial Application for ORIC-114 in Advanced Solid Tumors with EGFR or HER2 Exon 20 Alterations or HER2 Amplifications Read More »
eFFECTOR Therapeutics Provides Pipeline and Business Updates Portfolio News / Karina Tin January 24, 2022 eFFECTOR Therapeutics Provides Pipeline and Business Updates Read More »
A2 Bio to Present at ASCO-GI 2022 on Use of Next Generation Sequencing (NGS) to Identify GI Cancer Patients for Future TmodTM CAR T Therapy Portfolio News / Karina Tin January 18, 2022 A2 Bio to Present at ASCO-GI 2022 on Use of Next Generation Sequencing (NGS) to Identify GI Cancer Patients for Future TmodTM CAR T Therapy Read More »
Revolution Medicines Reports Progress Across Pipeline of Targeted Therapeutics for RAS-Addicted Cancers in Presentation at 40th Annual J.P. Morgan Healthcare Conference Portfolio News / Karina Tin January 11, 2022 Revolution Medicines Reports Progress Across Pipeline of Targeted Therapeutics for RAS-Addicted Cancers in Presentation at 40th Annual J.P. Morgan Healthcare Conference Read More »
NGM Bio Outlines 2022 Strategic Priorities Across Its Portfolio of Clinical-Stage Oncology, Retinal and Liver and Metabolic Programs Portfolio News / Karina Tin January 10, 2022 NGM Bio Outlines 2022 Strategic Priorities Across Its Portfolio of Clinical-Stage Oncology, Retinal and Liver and Metabolic Programs Read More »
Tenaya Therapeutics Provides 2022 Business Updates Portfolio News / Karina Tin January 10, 2022 Tenaya Therapeutics Provides 2022 Business Updates Read More »
Surrozen Announces Key 2022 Milestones for Lead Programs and Acceleration of Research Pipeline Portfolio News / Karina Tin January 10, 2022 Surrozen Announces Key 2022 Milestones for Lead Programs and Acceleration of Research Pipeline Read More »
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones Portfolio News / Karina Tin January 10, 2022 ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones Read More »
Nurix Therapeutics Advances Clinical and Preclinical Pipeline and Outlines 2022 Catalysts Portfolio News / Karina Tin January 10, 2022 Nurix Therapeutics Advances Clinical and Preclinical Pipeline and Outlines 2022 Catalysts Read More »